Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by XUEFANG LIU
Recombinant Human Lactoferrin Enhances the Efficacy of Triple Therapy in Mice Infected With Helicobacter Pylori
International Journal of Molecular Medicine
Medicine
Genetics
Related publications
Direct Activity of Recombinant Human Lactoferrin Against Helicobacter Pylori.
Journal of Clinical Microbiology
Microbiology
Systematic Review With Meta-Analysis: The Efficacy of Vonoprazan-Based Triple Therapy on Helicobacter Pylori Eradication
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
The Efficacy of Moxifloxacin-Containing Triple Therapy After Standard Triple, Sequential, or Concomitant Therapy Failure for Helicobacter Pylori Eradication in Korea
Gut and Liver
Hepatology
Gastroenterology
Evaluation of the Efficacy of Triple Therapy Regimen for Helicobacter Pylori Eradication in Gastrectomized Patients With Gastric Adenocarcinoma
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Probiotics Improve the Efficacy of Standard Triple Therapy in the Eradication of Helicobacter Pylori: A Meta-Analysis
Infection and Drug Resistance
Infectious Diseases
Pharmacology
Efficacy of Short-Term Triple Therapy With Amoxicillin, Clarithromycin and Proton Pump Inhibitor for Eradication of Helicobacter Pylori
Progress of Digestive Endoscopy(1972)
One-Day Quadruple Therapy Compared With 7-Day Triple Therapy for Helicobacter Pylori Infection
Archives of Internal Medicine
Addition of Bismuth to the Standard Triple Therapy for Helicobacter Pylori Infection
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Helicobacter Pylori-Specific CD4+ T Cells Home to and Accumulate in the Human Helicobacter Pylori-Infected Gastric Mucosa
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
